Core principle
Every deliverable has a named owner. AI produces working material (structured drafts, candidate summaries, flagged issues) that a qualified professional reviews, edits, and approves. At no point in any workflow does AI output go directly into a deliverable without human verification. This is not a disclaimer appended to make AI use sound responsible. It is a structural requirement embedded in every workflow card: defined review points, specific verification steps, and documented sign-off.What this means in practice
What AI handles well in med comms workflows
- Producing a structured first-draft summary of a Phase III paper in 2 minutes instead of 45
- Generating a candidate content outline from a briefing document and key message set
- Adapting a specialist-level summary for a GP or nurse audience
- Scanning a 20-page detail aid for language patterns commonly flagged in MLR review
- Extracting study design, endpoints, and results from a congress poster into a structured format
What AI cannot do — and should never be trusted to do
- Confirm that a hazard ratio, p-value, or confidence interval in a summary actually matches the source paper
- Determine whether a key message crosses from scientific education into promotional territory
- Decide which endpoints to foreground in a slide deck for a specific advisory board audience
- Judge whether a plain language summary accurately represents the benefit-risk balance for patients
- Bear accountability when a deliverable is signed off and sent to a client, regulator, or MLR committee
Decision points in every workflow
Each workflow card in this playbook includes explicit sections:- Where AI helps — bounded, specific tasks where AI adds value
- Where human judgement is essential — points where a trained professional must review, verify, or decide
- Human review checklist — a practical checklist for the review step
Why this matters for medical writing
Medical writing operates in a space where:- Accuracy is non-negotiable. A misrepresented endpoint, an overstated efficacy claim, or an omitted safety finding can have real consequences — for patients, for prescribers, and for regulatory standing.
- Context is everything. The same data point can be appropriate in a journal manuscript, misleading in a promotional piece, and incomprehensible in a patient leaflet. Only a trained professional can make that judgement.
- Accountability is personal. When a document is signed off, a named individual is accountable for its accuracy and compliance. AI cannot bear that accountability.
How to implement this principle
- Never submit AI-generated text without expert review. This applies to every deliverable: an internal summary, a client-facing slide deck, a congress highlights report. No exceptions by risk tier.
- Document where AI was used. Track which sections were AI-assisted in your project files. This is not bureaucracy; it tells the reviewer where to focus verification effort and supports client transparency.
- Review against sources, not just for readability. AI output reads fluently. That is the danger. A summary that sounds authoritative can contain transposed data points, merged study arms, or conclusions the authors did not draw. Always verify claims against the original source materials.
- Treat AI output as a working draft. The value is reaching a reviewable draft faster — getting from a blank page to a structured starting point. The review itself is not shortened; in some cases, it requires more attention, not less.
- Maintain clear sign-off protocols. The person who approves the final deliverable owns its accuracy, compliance, and completeness. The fact that AI was involved in production does not change their accountability.
Common failure modes
| Failure | What it looks like in practice | How to prevent it |
|---|---|---|
| Over-trust | A writer accepts an AI-generated summary without checking it against the paper. The summary transposes a primary and secondary endpoint result. The error enters a client slide deck. | Verify every data point against the source. Treat AI output the same way you would treat a junior writer’s first draft — it needs line-by-line checking. |
| Automation bias | MedCheckr flags no issues on a promotional piece. The writer assumes it is clean. MLR catches an unsubstantiated comparative claim the tool missed. | Automated screening is one input. It catches patterns, not context. The writer’s own compliance review still applies. |
| Accountability gap | An agency uses AI across multiple writers on a project. No one is clearly responsible for verifying the AI-assisted sections. A hallucinated data point reaches the client. | Assign a named reviewer to every AI-assisted deliverable. Document which sections used AI and who verified them. |
| Review fatigue | A medical writer reviews five AI-generated summaries in a row. By the fourth, they are skimming. An incorrect sample size passes through. | Use the structured checklist for every review. Batch AI-assisted QC in manageable sets. Do not review more than three AI-generated documents without a break. |
For agencies and teams
If you are implementing AI workflows across a team or agency:- Establish minimum review standards for AI-assisted content at each risk tier and write them into your SOPs
- Train writers and reviewers on the specific failure modes of AI in medical writing (hallucinated data, meaning drift, omitted qualifiers), not just generic “AI limitations”
- Track AI use in project management systems so reviewers, account leads, and clients have visibility
- Brief client services teams on how to discuss AI-assisted workflows with clients. Lead with the review framework and risk tiers, not the speed
- Do not position AI as a way to reduce QC time or headcount. Position it as a way to produce more reviewable first drafts, improve consistency across deliverables, and free up writer time for the work that requires expert judgement
Last reviewed: 15 April 2026 · 6 min read